Thursday, February 6, 2025
There is a wide range of stock market investing experience among the subscribers to my Dividend Hunter service. From the emails I receive, I know that it is easy for both beginners and more experienced investors to have trouble keeping up with how companies announce dividends and when you actually see the cash in your […]
Click the video above to watch Serge’s most recent market analysis
GameStop (GME) has become one of the most explosive stocks on the market. Over the last few days, GME ran from a low of $20 to a high of $310. Volume on Tuesday was up to 178.8 million shares, as compared to daily average volume of 24.18 million. All after Reddit forum, WallStreetBets reportedly fueled […]
I have been watching with great interest the successes and failures of different state and local coronavirus vaccination plans. I am struck by the inability to adjust to changing conditions brought on by a bureaucratic mindset. It varies greatly from the “flexibility is the key to air power” mindset that I formed in my days […]
With stock market valuations sitting near 20-year highs, investors are hoping corporate results and profit outlooks will help determine to what degree the valuations are justified. The catalyst that will drive the market to higher highs over the near-term will be the current fourth-quarter earnings season that will carry over into mid-February and a month […]
There have been several big movers in the stock market already in 2021. As expected, many of the highfliers from 2020—including stocks related to cryptocurrencies, electric vehicles, fuel cell technology, biotech, and others—continue to experience plenty of action. As anyone who’s traded in the market long enough knows, there’s almost always a hot investment. Maybe […]
Mobile video game maker Zynga (ZNGA) saw significant options activity last week. On a big volume day, ZNGA options traded 9x the normal options volume. 96% of the options action was in calls, which is generally a bullish sign. ZNGA has earnings on February 10th, and this could be a bet that the company is […]
For income investors, the last 11 months have been, to paraphrase Dickens, “the best of times, the worst of times.” The February-March 2020 market crash was especially brutal on the high-yield investment sectors. Without a lot of information, I had to analyze my Dividend Hunter recommendations and decide which were best to sell and which […]
To watch today’s Serge Berger Weekly options trade please click the video button.
Shares of Aclaris Therapeutics (ACRS) after announcing positive data from a Phase 2a trial of its rheumatoid arthritis treatment. “Aclaris Chief Medical Officer David Gordon said he believes the data supports the hypothesis that MK2 inhibition is an important novel target for treating immuno-inflammatory diseases, and he looks forward to progressing ATI-450 to Phase 2b,” […]
